<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02279628</url>
  </required_header>
  <id_info>
    <org_study_id>2012-004498-14</org_study_id>
    <nct_id>NCT02279628</nct_id>
  </id_info>
  <brief_title>Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section</brief_title>
  <official_title>Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section. Controlled Comparative Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maternite Regionale Universitaire</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The cesarean section is considered as a painful surgery during the post operative period.
      Mothers may need to move immediately after the surgery to take care of their babies. This may
      increase the risk of major pain and chronic pain. Thus, excellent postoperative analgesia is
      required so that mothers do not experience pain in caring for their baby. Currently, several
      techniques have been developed to manage postoperative pain related to c-section scar such as
      intrathecal morphine during spinal anesthesia or continuous pre-peritoneal wound
      infiltration. The comparison between anesthetic techniques has never been performed and it is
      still not know if the combination of intrathecal morphine plus continuous pre-peritoneal
      wound infiltration provide a synergistic or additional effect on pain relief.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to compare the efficacy of continuous wound infiltration versus
      intrathecal morphine for postoperative analgesia after scheduled cesarean section. The
      primary endpoint is morphine consumption during the first 48 postoperative hours.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine consumption during the first 48 postoperative hours</measure>
    <time_frame>at the 48th hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at rest and at mobilization</measure>
    <time_frame>Every 4 hours during the first 48 postoperative hours</time_frame>
    <description>The pain at rest and at mobilization will be evaluated with both Visual Analog scale and Verbal pain scale. The patient should describe the worst pain felt during the previous 4 hours in a lying position and at mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to restoration of bowel function</measure>
    <time_frame>within the first 48 postoperative hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Verbal and Visual analog pain scores in the first standing position</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients that required oral morphine</measure>
    <time_frame>At the 24th and 48th hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients that required local anesthetic rescue dose through the catheter</measure>
    <time_frame>At the 24th and 48th hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative rehabilitation survey</measure>
    <time_frame>At the 48th hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of side effect</measure>
    <time_frame>During the first 48 hours</time_frame>
    <description>Itching, nausea and vomiting, drowsiness, urinary retention, hypoventilation, other will be assessed with a questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative residual pain (DN4 survey)</measure>
    <time_frame>At 3 months postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Continuous wound infiltration alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spinal anesthesia will be performed with 10 mg bupivacain 0.5% hyperbaric, 3 μg sufentanil and 1 ml sodium chloride 0.9% (without morphine). Patient will then receive a continuous wound infiltration of ropivacaine 0.2% 8 ml/H via a preperitoneal catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intrathecal moprhine alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spinal anesthesia will be performed with 10 mg bupivacain 0.5% hyperbaric, 3 μg sufentanil and 0.1mg morphine. Patient will then receive a continuous wound infiltration of sodium chloride 0.9% 8 ml/H via a preperitoneal catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intrathecal morphine&amp;wound infiltration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spinal anesthesia will be performed with 10 mg bupivacain 0.5% hyperbaric, 3 μg sufentanil and 0.1mg morphine. Patient will then receive a continuous wound infiltration of ropivacaine 0.2% 8 ml/H via a preperitoneal catheter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Ropivicaine (0.2%) bolus of 10ml will be injected through the catheter after surgery and continuously infused during the postoperative period (8ml/H)</description>
    <arm_group_label>Continuous wound infiltration alone</arm_group_label>
    <arm_group_label>Intrathecal morphine&amp;wound infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Morphine will be injected intrathecally (100µg) and oral morphine will be given during the postoperative period</description>
    <arm_group_label>Intrathecal moprhine alone</arm_group_label>
    <arm_group_label>Intrathecal morphine&amp;wound infiltration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective Cesarean section

          -  Spinal anesthesia

          -  Singleton

          -  ASA ( Physical status score) 1 to 3

        Exclusion Criteria:

          -  Age &lt;18yrs

          -  BMI ≥ 45 kg/m2 or weight &lt; 45 kg

          -  Refusal to consent

          -  Urgent cesarean section

          -  Allergy to a medication used in the protocol

          -  Impaired hemostasis ou current infection

          -  Contra indication or failure of spinal anesthesia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hervé BOUAZIZ, MD., PhD.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology, Maternité Régionale Universitaire, CHU NANCY, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Florence VIAL, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Maternité Régionale Universitaire, CHU NANCY, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe GUERCI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Critical Care Medicine, CHU NANCY Brabois, FRANCE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florence VIAL, MD</last_name>
    <phone>+ 33 3 83 34 43 67</phone>
    <email>f.vial@maternite.chu-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Philippe GUERCI, MD</last_name>
    <phone>+33 3 83 15 73 99</phone>
    <email>p.guerci@chu-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maternité Régionale Universitaire (MRU)</name>
      <address>
        <city>Nancy</city>
        <state>Lorraine</state>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence VIAL, MD</last_name>
      <phone>+33 3 83 34 44 67</phone>
      <email>f.vial@maternite.chu-nancy.fr</email>
    </contact>
    <contact_backup>
      <last_name>Hervé BOUAZIZ, MD., PhD.</last_name>
      <phone>+33 3 83 34 44 67</phone>
      <email>h.bouaziz@chu-nancy.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2014</study_first_submitted>
  <study_first_submitted_qc>October 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2014</study_first_posted>
  <last_update_submitted>October 28, 2014</last_update_submitted>
  <last_update_submitted_qc>October 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>spinal anesthesia</keyword>
  <keyword>continuous wound infiltration</keyword>
  <keyword>intrathecal morphine</keyword>
  <keyword>oral morphine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

